Trans American Aquaculture, Inc (GRPS) — SEC Filings
Trans American Aquaculture, Inc (GRPS) — 21 SEC filings. Latest: 8-K (Apr 2, 2026). Includes 11 8-K, 4 10-Q, 2 10-Q/A.
View Trans American Aquaculture, Inc on SEC EDGAR
Overview
Trans American Aquaculture, Inc (GRPS) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q/A filed on Oct 16, 2025: Trans American Aquaculture, Inc. (GRPS) filed a 10-Q/A to revise its Balance Sheet and Consolidated Statements of Stockholders' Equity, primarily to reconcile common stock issued value and adjust a preferred stock line item. For the six months ended June 30, 2025, the company reported no revenue, a
Sentiment Summary
Across 21 filings, the sentiment breakdown is: 2 bearish, 18 neutral, 1 mixed. The dominant filing sentiment for Trans American Aquaculture, Inc is neutral.
Filing Type Overview
Trans American Aquaculture, Inc (GRPS) has filed 11 8-K, 2 10-Q/A, 4 10-Q, 2 10-K, 2 S-1/A with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (21)
Risk Profile
Risk Assessment: Of GRPS's 20 recent filings, 2 were flagged as high-risk, 9 as medium-risk, and 9 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $0 |
| Net Income | $(317,745) |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $198 |
| Operating Margin | N/A |
| Total Assets | $1,080,503 |
| Total Debt | $4,800,009 |
Key Executives
- Richard Goulding
- Adam Thomas
- Brian Higley, Esq.
Industry Context
The aquaculture industry, particularly shrimp farming, is capital-intensive and subject to biological risks, disease outbreaks, and market price volatility. Companies in this sector often face challenges in scaling operations, managing feed costs, and ensuring consistent product quality. Competition can be fierce, with both domestic and international players vying for market share.
Top Tags
Aquaculture (5) · 10-Q (4) · High Debt (2) · Penny Stock (2) · Reverse Acquisition (2) · SEC Filing (2) · material-agreement (2) · equity-sale (2) · corporate-governance (2) · material-definitive-agreement (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Revenue | $0 | For the six months ended June 30, 2025, a significant drop from $315,145 in 2024. |
| Net Loss | $(317,745) | For the six months ended June 30, 2025, an improvement from $(568,332) in 2024. |
| Total Assets | $1,080,503 | As of June 30, 2025, up from $948,015 at December 31, 2024. |
| Total Current Liabilities | $4,654,029 | As of June 30, 2025, an increase from $3,608,912 at December 31, 2024. |
| Accrued Interest Expense | $850,388 | As of June 30, 2025, a substantial increase from $114,568 at December 31, 2024. |
| Accumulated Deficit | $(5,993,312) | As of June 30, 2025, deepening from $(5,675,567) at December 31, 2024. |
| Common Shares Outstanding | 1,805,926,955 | As of October 9, 2025, indicating significant dilution potential. |
| Series D Preferred Stock Sale | $104,000 | Proceeds from GHS in March 2025 SPA for 114 shares. |
| Warrants Issued to GHS | 306,666,667 | Exercisable at $0.000115 per share, indicating potential future dilution. |
| Cash and Cash Equivalents | $198 | As of June 30, 2025, critically low for ongoing operations. |
| Total Stockholders' (Deficit) Equity | $(3,719,207) | as of June 30, 2025, worsening from $(3,221,985) at December 31, 2024 |
| General and Administrative Expenses | $182,961 | for six months ended June 30, 2025, down from $321,383 in 2024 |
| Number of Preferred Stock Series | 4 | Trans American Aquaculture has issued Series A, B, C, and D Preferred Stock, indicating a diversified approach to equity financing. |
| Latest Fiscal Year End | 2024 | The 10-K covers the fiscal year ending December 31, 2024, providing recent financial insights. |
| Earliest Preferred Stock Reporting Year | 2020 | Preferred stock data is reported as far back as December 31, 2020, showing a multi-year capital strategy. |
Forward-Looking Statements
- {"claim":"Trans American Aquaculture, Inc. will complete its public offering and begin trading.","entity":"Trans American Aquaculture, Inc.","targetDate":"2024-12-31","confidence":"medium"}
Frequently Asked Questions
What are the latest SEC filings for Trans American Aquaculture, Inc (GRPS)?
Trans American Aquaculture, Inc has 21 recent SEC filings from Jan 2024 to Apr 2026, including 11 8-K, 4 10-Q, 2 10-Q/A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of GRPS filings?
Across 21 filings, the sentiment breakdown is: 2 bearish, 18 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Trans American Aquaculture, Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Trans American Aquaculture, Inc (GRPS) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Trans American Aquaculture, Inc?
Key financial highlights from Trans American Aquaculture, Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for GRPS?
The investment thesis for GRPS includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Trans American Aquaculture, Inc?
Key executives identified across Trans American Aquaculture, Inc's filings include Richard Goulding, Adam Thomas, Brian Higley, Esq..
What are the main risk factors for Trans American Aquaculture, Inc stock?
Of GRPS's 20 assessed filings, 2 were flagged high-risk, 9 medium-risk, and 9 low-risk.
What are recent predictions and forward guidance from Trans American Aquaculture, Inc?
Recent forward-looking statements from Trans American Aquaculture, Inc include guidance on {"claim":"Trans American Aquaculture, Inc. will complete its public offering and begin trading.","entity":"Trans America.